Autologous hematopoietic stem-cell transplantation

August 29, 2016August 29, 2016

Opdivo Shows Potential in Specific Hodgkin’s Lymphoma Patients Whose Disease Progressed After Bone Marrow Transplant

News

Patients with classical Hodgkin’s lymphoma who progressed after receiving autologous hematopoietic stem cell transplant (HSCT) and treatment with Adcetris (brentuximab vedotin) may benefit from the PD-1 inhibitor Opdivo (nivolumab), according ... Read more

August 24, 2016August 24, 2016

Chemo Mix Using Treanda Before HSCT Seen of Benefit in Phase 2 Study

News

According to the results of a Phase 2 clinical trial, the triple combination of Treanda (bendamustine), Gemzar (gemcitabine), and Navelbine (vinorelbine) effectively induced complete remission in a large percentage of ... Read more

July 5, 2016July 5, 2016

Study of HSCT Donors for Lymphoma Patients Argues for Greater Use of Stem Cell Transplant Therapy

News

Lymphoma patients who undergo a hematopoietic stem cell transplant (HSCT) from a haploidentical-matched (tissue-matched) donor have similar survival rates to those receiving HSCT from HLA-matched sibling donors, and a lower risk of ... Read more

June 21, 2016June 21, 2016

HIV-Related Lymphoma: Autologous Hematopoietic Cell Transplant Recommended as Standard of Care

News

Patients with HIV-associated lymphoma who receive autologous hematopoietic cell transplantation (AHCT) have similar survival rates and complication rates than non-HIV lymphoma patients, suggesting that AHCT should be added as standard of ... Read more

April 6, 2016April 6, 2016

Relapsed Follicular Lymphoma Patients Appear to Benefit from Reduced-Intensity Allogeneic Transplants

News

Researchers have evaluated the efficacy of reduced-intensity allogeneic transplant as a treatment for patients with follicular lymphoma who experience disease recurrence after autologous stem cell transplant, finding it is an effective ... Read more

August 14, 2015August 14, 2015

Lymphoma Survivors at Increased Risk of Cardiac Problems After Stem Cell Transplantation

News

Results from a study published in the Journal of Clinical Oncology showed that heart failure and left ventricular systolic dysfunction occurred more regularly than previously reported in a population of ... Read more

July 15, 2015July 16, 2015

Lymphoma Survivors at Increased Long-Term Risk of Cardiac Complications After Autologous hematopoietic Stem-Cell Transplantation

News

Results from a recent study published in the Journal of Clinical Oncology showed that lymphoma survivors who underwent autologous hematopoietic stem-cell transplantation (HSCT) are at increased long-term risk of left ... Read more